These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1233532)

  • 21. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrapyramidal syndromes complicating neuroleptic drug therapy.
    Bharucha EP
    J Assoc Physicians India; 1976 Jun; 24(6):383-5. PubMed ID: 1022771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Occurrence of extrapyramidal-pyramidal syndrome during treatment with psychopharmaceutics].
    Ivanović M; Bosić D; Vucković S
    Neuropsihijatrija; 1974; 22(1-4):139-41. PubMed ID: 4470158
    [No Abstract]   [Full Text] [Related]  

  • 25. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ
    Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 27. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.
    Ghaemi SN; Hsu DJ; Rosenquist KJ; Pardo TB; Goodwin FK
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):209-13. PubMed ID: 16412546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant neuroleptic syndrome--its present status in Japan and clinical problems.
    Itoh H; Ohtsuka N; Ogita K; Yagi G; Miura S; Koga Y
    Folia Psychiatr Neurol Jpn; 1977; 31(4):559-76. PubMed ID: 608659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical vs clinical physiognomy of neuroleptics, with special reference to their antimanic effect.
    Dresse A
    Acta Psychiatr Belg; 1974 Sep; 74(5):485-7. PubMed ID: 4471028
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 33. [Failure effects and gender differences in perfectionism].
    Masson AM; Cadot M; Ansseau M
    Encephale; 2003; 29(2):125-35. PubMed ID: 14567164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L
    Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
    [No Abstract]   [Full Text] [Related]  

  • 35. A study of spectral integration and normalization in NMR-based metabonomic analyses.
    Webb-Robertson BJ; Lowry DF; Jarman KH; Harbo SJ; Meng QR; Fuciarelli AF; Pounds JG; Lee KM
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):830-6. PubMed ID: 15990265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Classification of neuroleptics].
    Lambert PA; Revol L
    Laval Med; 1966 Nov; 37(9):956-67. PubMed ID: 5983855
    [No Abstract]   [Full Text] [Related]  

  • 37. The main clinical classifications of neuroleptics.
    Collard J
    Acta Psychiatr Belg; 1974 Sep; 74(5):447-61. PubMed ID: 4157188
    [No Abstract]   [Full Text] [Related]  

  • 38. [Situation of sultopride among present-day neuroleptics].
    Maurel H; Pujol B
    Encephale; 1975; 1(1):19-24. PubMed ID: 1093844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.